AzTrials
AzTrials

Autonomy of Older PeoplePREPADNCT03992222

Prevention of the Older Adult's Loss of Autonomy at Home Through a Targeted Physical Exercise Program

A study testing Physical exercise programs PEP targeted on appropriate muscle strengthening devices allows in people with Autonomy of Older People, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Physical exercise program (PEP) have demonstrated their benefit to the health of older people. They are effective in functional performance and in the incidence and severity of falls. Read more about this study

Who is it for?
Ages 70 years and older
Conditions the study is for
Autonomy of Older People
What is being tested?
Physical exercise programs PEP targeted on appropriate muscle strengthening devices allows
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
280 participants
Where
1 siteFrance
Study dates
19 Jan 2019to Jul 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 70 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • People over 70 years old
  • Living at home
  • With at least one instrumental activity of altered daily life (a disturbed criterion on the IADL scale) and making a request to set up a housekeeper.
  • Major, able to give their consent
  • Having signed the informed consent
  • Affiliation to a social security scheme,

Who cannot join

  • Surgical procedure within 6 months on the hip or knee,
  • myocardial infarction or cerebrovascular accident diagnosed within 6 months,
  • Respiratory insufficiency requiring long-term oxygen therapy
  • Heart failure requiring hospitalization in the previous month or considered severe by the cardiologist
  • Known or disabling muscle or joint pathology
  • Subject benefiting from rehabilitation through physiotherapy sessions in progress or not wishing to stop physical exercise workshops
  • Subject already in loss of autonomy for the ADL
  • Life expectancy of less than 6 months any cause combined

Trial locations and contacts

1 site in 1 country.

France1 site
  • Hopital René Muret

    Sevran

Other trials in France

About this study

Official title: Prevention of the Older Adult's Loss of Autonomy at Home Through a Physical Exercise Program Targeted at Adapted Muscle Strengthening Devices

Physical exercise program (PEP) have demonstrated their benefit to the health of older people. They are effective in functional performance and in the incidence and severity of falls.

We hypothesize that intervention with targeted Physical exercise programs PEP on appropriate muscle strengthening devices allows, through its action on the muscle, to slow down the loss of autonomy in the elderly living in the home. Our main objective is to evaluate the impact of a PEP, targeted on adapted muscle strengthening devices, on the loss of autonomy for the acts of daily life in the person aged over 70 living at home.

Read the detailed description

The elderly will be identified during their call in the home centers of the town halls to get a housekeeper. After information, inclusion and randomization into two groups in the consultation site, the intervention group volunteers will follow the PEP for 24 weeks; the control group volunteers will receive a counseling booklet. Both groups will be followed at week 24 and 52.

Being tested
Physical exercise programs PEP targeted on appropriate muscle strengthening devices allows

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Physical exercise programs PEP targeted on appropriate muscle strengthening devices allowsDevice

    administration of a Physical exercise program for 24 weeks.The participants will be followed at the 24 and 52nd weeks.

Study groups in NCT03992222
Study groupRoleWhat they receive
administration of a physical exercise programmeExperimentaladministration of a Physical exercise program for 24 weeks.
Receives: Device: Physical exercise programs PEP targeted on appropriate muscle strengthening devices allows
controlNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Percentage of people without activities of daily living (LDA) assessed by the 12-month Katz questionnaire in the intervention group compared to the control group.

    To evaluate the impact of targeted PEEP on appropriate muscle strengthening devices, on the loss of autonomy for the acts of daily life in the person over 70 years old living at home

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Jun 2019
  2. Study start19 Jan 2019
  3. Primary completionJul 2022 (estimated)
  4. Study completionJul 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
280 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03992222
Sponsor's protocol ID
K 170 919
Acronym
PREPAD
Status last verified
Jan 2019
First submitted
18 Jun 2019
Last updated
9 Jul 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Physical exercise programs PEP targeted on appropriate muscle strengthening devices allows in people with Autonomy of Older People, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 9 Jul 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Percentage of people without activities of daily living (LDA) assessed by the 12-month Katz questionnaire in the intervention group compared to the control group. (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jul 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in